Anar Almazkhanli
Research Subjects
Anar Almazkhanli has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Rashad Sholan
Scientific Research Center State Security Service Military Hospital Baku Azerbaijan
8 shared publications - Rufat Aliyev
Scientific Research Center, State Security Service Military Hospital, Baku, Azerbaijan
8 shared publications - Malahat Sultan
Department of Radiology, Azerbaijan Medical University, Baku, Azerbaijan
6 shared publications - Nargiz Bakhshaliyeva
Department of Kidney Diseases and Organ Transplantation, State Security Service Military Hospital, Baku, Azerbaijan
4 shared publications - Rahman Ismayilov
Department of Kidney Diseases and Organ Transplantation, State Security Service Military Hospital, Baku, Azerbaijan
3 shared publications - Seymur Karimov
Department of Kidney Diseases and Organ Transplantation, State Security Service Military Hospital, Baku, Azerbaijan
3 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Wolters Kluwer Health in Formosan Journal of Surgery
Cystectomy for Refractory Interstitial Cystitis/Bladder Pain Syndrome: A Retrospective Study from Azerbaijan
Background: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition causing persistent bladder-related pain, pressure, or discomfort, significantly impairing quality of life. Cystectomy is a last-resort treatment for severe, refractory cases, but data on outcomes, particularly from specific regions, remain limited. Materials and Methods: This retrospective cohort study analyzed 16 Azerbaijani IC/BPS patients who underwent supratrigonal or total cystectomy between 2014 and 2024. Clinical, radiological, and surgical data were collected, with symptom severity assessed preoperatively and three months postoperatively using the interstitial cystitis symptom index (ICSI), interstitial cystitis problem index (ICPI), and visual analog scale (VAS) for pain. Results: The median age was 57 years, with 75% female. Median symptom duration was 8 years (range: 3-12), anesthetic bladder capacity was 75 mL (range: 40-140), and all patients had Hunner lesions. Surgical interventions included supratrigonal cystectomy with ileal augmentation (12.5%) and simple cystectomy with Bricker ileal conduit diversion (87.5%). Median ICSI scores reduced from 17 (range: 15–19) to 6 (range: 4–8), ICPI from 13 (range: 12–16) to 5 (range: 4–9), and VAS pain scores from 9 (range: 8–10) to 4 (range: 3–5) at the third postoperative month (all p < 0.001). No perioperative complications or in-hospital mortalities occurred, with a median hospital stay of 7 days (range: 6-11). Conclusions: Cystectomy provided substantial symptomatic relief and improved quality-of-life indices in patients with severe, refractory IC/BPS. These findings underscore its role as an effective but complex treatment option for carefully selected patients.
- 4 September 2026
- Published by Wolters Kluwer Health in Formosan Journal of Surgery
Open AccessCystectomy for Refractory Interstitial Cystitis/Bladder Pain Syndrome: A Retrospective Study from Azerbaijan
Background: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition causing persistent bladder-related pain, pressure, or discomfort, significantly impairing quality of life. Cystectomy is a last-resort treatment for severe, refractory cases, but data on outcomes, particularly from specific regions, remain limited. Materials and Methods: This retrospective cohort study analyzed 16 Azerbaijani IC/BPS patients who underwent supratrigonal or total cystectomy between 2014 and 2024. Clinical, radiological, and surgical data were collected, with symptom severity assessed preoperatively and three months postoperatively using the interstitial cystitis symptom index (ICSI), interstitial cystitis problem index (ICPI), and visual analog scale (VAS) for pain. Results: The median age was 57 years, with 75% female. Median symptom duration was 8 years (range: 3-12), anesthetic bladder capacity was 75 mL (range: 40-140), and all patients had Hunner lesions. Surgical interventions included supratrigonal cystectomy with ileal augmentation (12.5%) and simple cystectomy with Bricker ileal conduit diversion (87.5%). Median ICSI scores reduced from 17 (range: 15–19) to 6 (range: 4–8), ICPI from 13 (range: 12–16) to 5 (range: 4–9), and VAS pain scores from 9 (range: 8–10) to 4 (range: 3–5) at the third postoperative month (all p < 0.001). No perioperative complications or in-hospital mortalities occurred, with a median hospital stay of 7 days (range: 6-11). Conclusions: Cystectomy provided substantial symptomatic relief and improved quality-of-life indices in patients with severe, refractory IC/BPS. These findings underscore its role as an effective but complex treatment option for carefully selected patients.
- Open Access
- 12 April 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (4) , e72532
Successful Kidney Transplantation in Turner Syndrome: A Case for Feasibility and Favorable Outcomes
Turner syndrome (TS) leads to various abnormalities, including renal malformations that can progress to end‐stage renal disease (ESRD). Although rarely performed in patients with TS, renal transplantation offers significant benefits over dialysis. We report the case of a 34‐year‐old female with TS and ESRD who underwent a successful living‐donor kidney transplantation. Preoperative imaging revealed atrophic, malformed native kidneys located entirely in the pelvic region. A suitable graft bed was meticulously created in the right iliac fossa without the need for native nephrectomy. At the 9‐month postoperative follow‐up, the patient demonstrated excellent and stable graft function. This case highlights the feasibility of kidney transplantation in patients with TS and underscores the importance of careful preoperative planning and a multidisciplinary approach to overcome unique anatomical challenges.
- 12 April 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (4) , e72532
Open AccessSuccessful Kidney Transplantation in Turner Syndrome: A Case for Feasibility and Favorable Outcomes
Turner syndrome (TS) leads to various abnormalities, including renal malformations that can progress to end‐stage renal disease (ESRD). Although rarely performed in patients with TS, renal transplantation offers significant benefits over dialysis. We report the case of a 34‐year‐old female with TS and ESRD who underwent a successful living‐donor kidney transplantation. Preoperative imaging revealed atrophic, malformed native kidneys located entirely in the pelvic region. A suitable graft bed was meticulously created in the right iliac fossa without the need for native nephrectomy. At the 9‐month postoperative follow‐up, the patient demonstrated excellent and stable graft function. This case highlights the feasibility of kidney transplantation in patients with TS and underscores the importance of careful preoperative planning and a multidisciplinary approach to overcome unique anatomical challenges.
- Open Access
- 3 July 2025
- Published by Elsevier in Surgery in Practice and Science
- Vol. 22, 100296
Single-surgeon outcomes of open radical cystectomy for muscle-invasive bladder cancer: Experience from a tertiary center in Azerbaijan
- 3 July 2025
- Published by Elsevier in Surgery in Practice and Science
- Vol. 22, 100296
Open AccessSingle-surgeon outcomes of open radical cystectomy for muscle-invasive bladder cancer: Experience from a tertiary center in Azerbaijan
- 11 May 2025
- Published by S. Karger AG in Urologia Internationalis
- Vol. 110 (1) , 48-54
Long-Term Prospective Evaluation of Li-ESWT with or without PDE5 Inhibitors for Erectile Dysfunction following Nerve-Sparing Radical Prostatectomy
Introduction: Erectile dysfunction (ED) is a common complication following radical prostatectomy (RP). Although phosphodiesterase type 5 inhibitors (PDE5is) are used for penile rehabilitation, their efficacy post-RP is limited. Low-intensity extracorporeal shockwave therapy (Li-ESWT) has emerged as a potential noninvasive treatment, promoting tissue regeneration. This study evaluates the effectiveness of Li-ESWT, with or without PDE5i, for post-RP ED. Methods: This prospective study included 104 patients who underwent nerve-sparing RP and received Li-ESWT. Patients were divided into two groups: group 1 received daily 5 mg tadalafil along with Li-ESWT, while group 2 received Li-ESWT alone. Erectile function was assessed using the International Index of Erectile Function (IIEF-5) at baseline, 6, 12, and 24 months postoperatively. Results: The preoperative mean IIEF-5 score was 15.7 ± 4.7, with 54.8% of patients scoring below 17. Postoperatively, significant improvements in IIEF-5 scores were observed at 12 and 24 months in both groups compared to the 6th month. In patients with preoperative IIEF-5 <17, group 1 showed significantly greater improvement in IIEF-5 scores compared to group 2 (p = 0.008). No significant difference was observed between the groups in patients with preoperative IIEF-5 ≥17 (p = 0.893). Conclusion: Li-ESWT is an effective treatment for ED following nerve-sparing RP, with or without PDE5i. In patients with mild-to-moderate or greater preoperative ED, the combination of PDE5i and Li-ESWT may provide additional benefits, whereas Li-ESWT alone appears sufficient for those with milder cases.
- 11 May 2025
- Published by S. Karger AG in Urologia Internationalis
- Vol. 110 (1) , 48-54
Long-Term Prospective Evaluation of Li-ESWT with or without PDE5 Inhibitors for Erectile Dysfunction following Nerve-Sparing Radical Prostatectomy
Introduction: Erectile dysfunction (ED) is a common complication following radical prostatectomy (RP). Although phosphodiesterase type 5 inhibitors (PDE5is) are used for penile rehabilitation, their efficacy post-RP is limited. Low-intensity extracorporeal shockwave therapy (Li-ESWT) has emerged as a potential noninvasive treatment, promoting tissue regeneration. This study evaluates the effectiveness of Li-ESWT, with or without PDE5i, for post-RP ED. Methods: This prospective study included 104 patients who underwent nerve-sparing RP and received Li-ESWT. Patients were divided into two groups: group 1 received daily 5 mg tadalafil along with Li-ESWT, while group 2 received Li-ESWT alone. Erectile function was assessed using the International Index of Erectile Function (IIEF-5) at baseline, 6, 12, and 24 months postoperatively. Results: The preoperative mean IIEF-5 score was 15.7 ± 4.7, with 54.8% of patients scoring below 17. Postoperatively, significant improvements in IIEF-5 scores were observed at 12 and 24 months in both groups compared to the 6th month. In patients with preoperative IIEF-5 <17, group 1 showed significantly greater improvement in IIEF-5 scores compared to group 2 (p = 0.008). No significant difference was observed between the groups in patients with preoperative IIEF-5 ≥17 (p = 0.893). Conclusion: Li-ESWT is an effective treatment for ED following nerve-sparing RP, with or without PDE5i. In patients with mild-to-moderate or greater preoperative ED, the combination of PDE5i and Li-ESWT may provide additional benefits, whereas Li-ESWT alone appears sufficient for those with milder cases.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Medicine
- Vol. 2025 (1)
Renal Transplant in a Bardet–Biedl Syndrome Patient: A First Case From Azerbaijan
Introduction: Bardet–Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy characterized by multisystem involvement, with renal pathology, including end‐stage renal disease, being a major cause of morbidity and mortality. Case Presentation: This case report presents a 14‐year‐old boy with BBS and end‐stage renal disease who underwent a successful living donor kidney transplantation, marking the first reported case in Azerbaijan. Despite multiple comorbidities, including obesity, hypertension, and high panel reactive antibody levels, the patient achieved stable graft function with a rapid postoperative creatinine decline. Postoperative management focused on immunosuppression and lifestyle adjustments. Conclusion: This case contributes to the limited literature on BBS, highlighting both the challenges and favorable outcomes of renal transplantation in patients with this rare genetic disorder.
- 1 January 2025
- Published by Wiley in Case Reports in Medicine
- Vol. 2025 (1)
Open AccessRenal Transplant in a Bardet–Biedl Syndrome Patient: A First Case From Azerbaijan
Introduction: Bardet–Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy characterized by multisystem involvement, with renal pathology, including end‐stage renal disease, being a major cause of morbidity and mortality. Case Presentation: This case report presents a 14‐year‐old boy with BBS and end‐stage renal disease who underwent a successful living donor kidney transplantation, marking the first reported case in Azerbaijan. Despite multiple comorbidities, including obesity, hypertension, and high panel reactive antibody levels, the patient achieved stable graft function with a rapid postoperative creatinine decline. Postoperative management focused on immunosuppression and lifestyle adjustments. Conclusion: This case contributes to the limited literature on BBS, highlighting both the challenges and favorable outcomes of renal transplantation in patients with this rare genetic disorder.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Medicine
- Vol. 2025 (1) , 3103124
Metachronous Bilateral Nephrectomy, Supratrigonal Cystectomy, and Living Donor Renal Transplantation in a Patient With Chronic Kidney Disease due to Interstitial Cystitis and Total Urethral Stricture
Introduction: Interstitial cystitis (IC) is a chronic pelvic pain syndrome characterized by urinary urgency, frequency, and pain. Although the exact cause of IC is unclear, severe cases may lead to chronic kidney disease (CKD), requiring complex surgical interventions. Case Presentation: This case report presents a 46‐year‐old male with IC complicated by CKD secondary to total urethral stricture. Following recurrent surgeries for urinary tract infections and strictures, the patient underwent a staged surgical approach involving bilateral nephrectomy, supratrigonal cystectomy, and renal transplantation with Bricker ileal conduit diversion. Postoperatively, renal function was fully restored, and IC‐related symptoms resolved. Conclusion: This case underscores the efficacy of major surgical interventions for refractory IC, highlighting the need for individualized, multidisciplinary management in complex cases.
- 1 January 2025
- Published by Wiley in Case Reports in Medicine
- Vol. 2025 (1) , 3103124
Open AccessMetachronous Bilateral Nephrectomy, Supratrigonal Cystectomy, and Living Donor Renal Transplantation in a Patient With Chronic Kidney Disease due to Interstitial Cystitis and Total Urethral Stricture
Introduction: Interstitial cystitis (IC) is a chronic pelvic pain syndrome characterized by urinary urgency, frequency, and pain. Although the exact cause of IC is unclear, severe cases may lead to chronic kidney disease (CKD), requiring complex surgical interventions. Case Presentation: This case report presents a 46‐year‐old male with IC complicated by CKD secondary to total urethral stricture. Following recurrent surgeries for urinary tract infections and strictures, the patient underwent a staged surgical approach involving bilateral nephrectomy, supratrigonal cystectomy, and renal transplantation with Bricker ileal conduit diversion. Postoperatively, renal function was fully restored, and IC‐related symptoms resolved. Conclusion: This case underscores the efficacy of major surgical interventions for refractory IC, highlighting the need for individualized, multidisciplinary management in complex cases.
- Open Access
- 23 November 2024
- Published by Elsevier in Urology Case Reports
- Vol. 58, 102890
Renal PEComa in a young male: A case report and insights from the literature
- 23 November 2024
- Published by Elsevier in Urology Case Reports
- Vol. 58, 102890
Open AccessRenal PEComa in a young male: A case report and insights from the literature
- 17 November 2024
- Published by ECO-Vector LLC in Urology Reports (St. - Petersburg)
- Vol. 14 (3) , 271-277
Panel-reactive antibodies in kidney transplantation for patients with end-stage renal failure
BACKGROUND: Kidney transplantation is a recognized method of treating patients with end–stage kidney disease. However, the risk of graft loss is not excluded. In Azerbaijan, kidney transplantation is mainly performed from living donors; nevertheless, there is little data on the panel-reactive antibodies (PRA) and its use in the transplantation program. AIM: To evaluate the prevalence of positive panel-reactive antibodies (PRA) and short-term outcomes of living donor kidney transplantation. MATERIALS AND METHODS: Within 6 months after kidney transplantation, 113 recipients were followed up. All patients underwent their first transplantation. Complement-dependent cytotoxicity cross-matching, HLA typing, and flow cytometry cross-matching were carried out. Flow cytometric analysis was applied to detect PRA. The positive response percentage is presented by the percentage of events shifted to the right of the cutoff point. Data were analyzed using SPSS 16.0 statistical software. RESULTS: Among the examined patients, men predominated. In PRA-positive patients (n = 20), the dialysis duration was on average 22.3% longer than in PRA-negative patients (n = 93). 35.0% of PRA-positive patients had class I PRA, 30.0% of patients had class II PRA, and 35.0% had class I + II PRA. In 40.0% of cases, positive PRA had high sensitization 50% (predominantly class II), and the remaining 60.0% had PRA from 10% to 50%. Sensitizing factors were more common in the PRA-positive group (p 0.05). After 6 months of folow-up, the mean creatinine level was 183.4 ± 68.84 nmol/l in the PRA-positive group and 198.15 ± 108.23 nmol/l in the PRA-negative group (p = 0.91). The overall emptying rate was 4.4% (n = 5), with all 5 cases being in the PRA-negative group. No deaths were observed during the follow-up period. CONCLUSIONS: PRA positive patients usually have some sensitizing event such as pregnancy or blood transfusion. The transfusion itself was not a significant factor of sensitization in this study. Patients with high PRA levels require more thorough examination.
- 17 November 2024
- Published by ECO-Vector LLC in Urology Reports (St. - Petersburg)
- Vol. 14 (3) , 271-277
Panel-reactive antibodies in kidney transplantation for patients with end-stage renal failure
BACKGROUND: Kidney transplantation is a recognized method of treating patients with end–stage kidney disease. However, the risk of graft loss is not excluded. In Azerbaijan, kidney transplantation is mainly performed from living donors; nevertheless, there is little data on the panel-reactive antibodies (PRA) and its use in the transplantation program. AIM: To evaluate the prevalence of positive panel-reactive antibodies (PRA) and short-term outcomes of living donor kidney transplantation. MATERIALS AND METHODS: Within 6 months after kidney transplantation, 113 recipients were followed up. All patients underwent their first transplantation. Complement-dependent cytotoxicity cross-matching, HLA typing, and flow cytometry cross-matching were carried out. Flow cytometric analysis was applied to detect PRA. The positive response percentage is presented by the percentage of events shifted to the right of the cutoff point. Data were analyzed using SPSS 16.0 statistical software. RESULTS: Among the examined patients, men predominated. In PRA-positive patients (n = 20), the dialysis duration was on average 22.3% longer than in PRA-negative patients (n = 93). 35.0% of PRA-positive patients had class I PRA, 30.0% of patients had class II PRA, and 35.0% had class I + II PRA. In 40.0% of cases, positive PRA had high sensitization 50% (predominantly class II), and the remaining 60.0% had PRA from 10% to 50%. Sensitizing factors were more common in the PRA-positive group (p 0.05). After 6 months of folow-up, the mean creatinine level was 183.4 ± 68.84 nmol/l in the PRA-positive group and 198.15 ± 108.23 nmol/l in the PRA-negative group (p = 0.91). The overall emptying rate was 4.4% (n = 5), with all 5 cases being in the PRA-negative group. No deaths were observed during the follow-up period. CONCLUSIONS: PRA positive patients usually have some sensitizing event such as pregnancy or blood transfusion. The transfusion itself was not a significant factor of sensitization in this study. Patients with high PRA levels require more thorough examination.